M J Maisels1, E A Kring, J DeRidder. 1. Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI 48073, USA. jmaisels@beaumont.edu
Abstract
OBJECTIVE: We wished to compare the efficacy of light-emitting diode (LED) phototherapy with special blue fluorescent (BB) tube phototherapy in the treatment of neonatal hyperbilirubinemia. STUDY DESIGN: We randomly assigned 66 infants >or=35 weeks of gestation to receive phototherapy using an LED device or BB. In addition to phototherapy from above, all infants also received phototherapy from below using four BB tubes or a fiberoptic pad. RESULT: After 15+/-5 h of phototherapy, the rate of decline in the total serum bilirubin (TSB) was 0.35+/-0.25 mg/dl/h in the LED group vs 0.27+/-0.25 mg/dl/h in the BB group (P=0.20). CONCLUSION:LED phototherapy is as effective as BB phototherapy in lowering serum bilirubin levels in term and near-term newborns.
RCT Entities:
OBJECTIVE: We wished to compare the efficacy of light-emitting diode (LED) phototherapy with special blue fluorescent (BB) tube phototherapy in the treatment of neonatal hyperbilirubinemia. STUDY DESIGN: We randomly assigned 66 infants >or=35 weeks of gestation to receive phototherapy using an LED device or BB. In addition to phototherapy from above, all infants also received phototherapy from below using four BB tubes or a fiberoptic pad. RESULT: After 15+/-5 h of phototherapy, the rate of decline in the total serum bilirubin (TSB) was 0.35+/-0.25 mg/dl/h in the LED group vs 0.27+/-0.25 mg/dl/h in the BB group (P=0.20). CONCLUSION: LED phototherapy is as effective as BB phototherapy in lowering serum bilirubin levels in term and near-term newborns.
Authors: Amy R Borden; Katie M Satrom; Paul Wratkowski; Thomas N George; Constance A Adkisson; Hendrik J Vreman; Austin P Johnson; Kent J Nichols; Tina M Slusher Journal: Neonatology Date: 2018-01-31 Impact factor: 4.035
Authors: B H Morris; J E Tyson; D K Stevenson; W Oh; D L Phelps; T M O'Shea; G E McDavid; K P Van Meurs; B R Vohr; C Grisby; Q Yao; S Kandefer; D Wallace; R D Higgins Journal: J Perinatol Date: 2012-04-12 Impact factor: 2.521